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Abstract
Background: Non-hip non-vertebral fractures (NHNV) constitute the majority of
osteoporotic fractures but few studies have examined the association between these fractures,
co-morbidity and mortality.

Objective: To examine the relationship between individual non-hip non-vertebral fractures,
co-morbidities and mortality.

Methods:
Prospective population-based cohort of 267,043 subjects (45 and Up Study, Australia) had
baseline questionnaires linked to hospital administrative and all-cause mortality data from
2006 - 2013. Associations between fracture and mortality examined using multivariate, time
dependent Cox models, adjusted for age, prior fracture, body mass index, smoking and comorbidities (cardiovascular disease, diabetes, stroke, thrombosis and cancer) and survival
function curves. Population attributable fraction calculated for each level of risk exposure.

Results:
During 1,490,651 person-years, women and men experienced 7,571 and 4,571 fractures and
7,064 deaths and 11,078 deaths, respectively. In addition to hip and vertebral fractures,
pelvis, humerus, clavicle, rib, proximal tibia/fibula, elbow and distal forearm fractures in both
sexes, and ankle fractures in men, were associated with increased multivariable adjusted
mortality hazard ratios ranging from 1.3 to 3.4. Co-morbidity independently added to
mortality such that a woman with a humeral fracture and one co-morbidity had a similarly
reduced 5 year survival to that of a woman with a hip fracture and no co-morbidities.
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Population mortality attributable to any fracture without co-morbidity was 9.2% in women
and 5.3% in men.

Conclusion:
All proximal non-hip, non-vertebral fractures in women and men were associated with
increased mortality risk. Co-existent co-morbidities independently further increased
mortality. Population attributable risk for mortality for fracture was similar to cardiovascular
disease and diabetes, highlighting their importance and potential benefit for early intervention
and treatment.

Keywords: Epidemiology, Aging, Practice/ Policy-related issues
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Introduction
Premature mortality post-fracture is well established for hip and vertebral fractures (1-3).
There is increasing evidence that a range of other, non-hip non-vertebral (NHNV),
osteoporotic fractures are also associated with increased mortality (4-6). However, published
data are inconsistent, particularly for distal forearm fractures (7, 8), or lacking for many other
fractures.

This potential association is important because NHNV fractures account for over 50% of
fractures. Compared to hip and vertebral fractures, they receive less attention (9), possibly
due to clinicians’ perception they are not associated with adverse consequences, or to
difficulties accessing accurate data as they often do not require hospital admission. However,
there is increasing evidence that NHNV fractures contribute significantly to the burden of
subsequent fractures (10, 11) and increased premature mortality (5, 12, 13).

Previous studies of NHNV fractures and mortality have a number of limitations (8, 12, 1417). In particular, apart from sites such as the humerus (17, 18) and distal forearm (8, 19),
NHNV fractures are commonly grouped (20, 21), due to limited fracture numbers for specific
sites. In addition, data on co-morbidities, and other potential confounders for mortality, are
often lacking.

To overcome some of these limitations, we used a large population cohort with baseline comorbidity data and linkage capabilities to examine the relationship of hip, vertebral and
multiple NHNV fracture sites with mortality. The study aims were to examine: (1) the

5

relationship between mortality and individual NHNV fracture sites, and (2) the independent
contribution of fracture and co-morbidity to mortality.

Subjects and Methods
The Sax Institute’s 45 and Up study is a prospective cohort study of over 260,000 residents of
New South Wales (NSW), Australia. NSW’s population accounts for one-third of Australia’s
population. The study, described previously (22), included subjects 45 and older who were
invited to participate via random sampling of the Department of Human Services (formerly
Medicare Australia) enrolment database, which provides near complete coverage of the
Australian population. To allow for deaths and loss to follow-up, the study over-sampled by a
factor of two, individuals 80+ years and individuals in rural areas. Recruitment occurred
between 2005 and 2009. The response rate was 18% and the study cohort was healthier and
better educated than the general NSW population (23). Participants completed a baseline
questionnaire and consented to data linkage to a number of administrative health datasets. For
this analysis participants were followed until 31 December 2013. To ensure a minimum 12month follow-up post-fracture, participants who fractured in the last follow-up year were
excluded.

Questionnaire Variables
Demographic data (age, date of recruitment, sex), lifestyle (smoking status, body mass index
(BMI)) and co-morbidities were obtained from the baseline questionnaire. Co-morbidities
included cardiovascular disease, cerebrovascular disease, thrombotic disorders, diabetes,
melanoma, breast cancer, prostate cancer, and all other cancers including non-melanoma skin
cancer and prior fracture within the last five years. For co-morbidities, participants were
asked whether “a doctor ever told you that you have” the condition (Yes/No). BMI was
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derived from self-reported height and weight. Smoking status was classified as never,
previous or current. Alcohol intake was classified in three categories as none; within the
Australian National Health and Medical Research Council guideline recommendations (≤ 2
standard drinks/day for women and ≤ 4 standard drinks/day for men, with 2 alcohol free days
per week for both sexes); and exceeding guidelines.

Linked databases
1. NSW Ministry of Health: Emergency Department Data Collection (EDDC): The EDDC
collates presentations to all NSW public hospitals Emergency Departments. All
Emergency Department presentations for diagnoses of fractures were used. International
Classification of Diseases (ICD-10) (24) and Systematized Nomenclature of MedicineClinical Terms (SNOMED-CT) (25) codes were used to identify fractures.
2. NSW Ministry of Health: Admitted Patient Data Collection (APDC): The APDC collates
inpatient separations (discharges, transfers and deaths) from all NSW public, private, and
repatriation hospitals and private day procedure centres. These data include demographic
characteristics, diagnoses and length of stay for individual episodes of hospital care.
Diagnoses are coded according to the Australian modification
3. NSW Registry of Births, Deaths and Marriages (RBDM): All-cause mortality data were
identified using death registrations.

Baseline questionnaire data from the 45 and Up Study were linked to the EDDC data, APDC
data, and RBDM data. Probabilistic record linkage was performed by the Centre for Health
Record Linkage. The 45 and Up Study was approved by the University of NSW Human
Research Ethics Committee. Ethics approval for the current study was obtained from the
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NSW Population Health Services Research Ethics Committee. Informed consent was not
required for the current study as only de-identified data was used.

Fracture identification
Fractures were identified through a combination of SNOMED-CT and ICD-10 diagnosis
codes from the APDC and EDDC as outlined above, and also using the Australian
Classification of Health Interventions (ACHI) (26) procedure codes to capture fractures
presenting as a day procedure. All SNOMED-CT and ICD-10 diagnosis codes suggesting
fractures resulting from high trauma and pathological fractures were excluded. In participants
with 2 or more fractures during one admission, only the more axial fracture, deemed the most
severe, was counted.

Outcome measures
The primary outcome was all-cause mortality following each fracture type adjusted for age,
lifestyle factors and co-morbidities.

Statistical analysis
Participants who died were compared to those alive at the study end for women and men
separately. Student’s t-test was used to compare baseline characteristics for continuous
variables and Pearson’s 𝝌𝝌2 test for categorical variables. Fracture incidence and mortality
were calculated as fractures and deaths per 1000 person-years of follow-up. Fracture

incidence was calculated for age groups: 45-59, 60-74 and 75+. Individual covariates were
examined for their relationship with mortality using Cox’s proportional hazard models.
Significance and 95% confidence intervals were calculated assuming a Poisson distribution.
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Mortality rates were age standardised to the 2001 Australian population as recommended by
the Australian Bureau of Statistics. As overall mortality rate of the study cohort was lower
than the general Australian population, particularly in the 85+ age cohort, standardised
mortality ratios, comparing the cohort and NSW population, are not presented. Mortality
differences were compared within the cohort between fracture and non-fracture participants
in several analyses.

Cox’s proportional hazards regression was used to examine the association between fracture
type and mortality with adjustment for covariates. Fracture was included as a time-dependent
variable. Survival time was measured from recruitment until death or censor date. The
proportional hazards assumption was checked for each variable by examining the residual
plots. Thus age- and sex-specific adjusted hazard ratios (HR) were derived. Body mass index
were missing in 11000 women (8.5%) and 7650 men (6.3%). These participants were
excluded from the final modelling. Sensitivity analysis with imputation using the median
BMI did not change the analysis meaningfully.

To examine the effect of co-morbidities on survival for different fracture types, estimated
survival function curves with covariates were plotted using the baseline function in SAS. We
chose humeral fracture as representative of a NHNV fracture to compare with the known
increased mortality of hip fracture. Curves were plotted for women and men aged 60 or 80
for none, one or two co-morbidities, in addition to fracture.

To calculate population attributable fraction, the heuristic approach was taken (17) using
combinations of six key risks (fracture during the study; baseline cardiovascular disease,
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diabetes, stroke, cancer and thrombosis) resulting in 64 possible exposure levels. Participants
who did not fracture, with no co-morbidities were the reference.

Analyses were performed using SAS 9.3 (SAS Institute, Inc. Cary, NC, USA).
Results
The study included data from 141,342 women and 122,877 men. Mean age (SD) was 61.8
(11.1) years in women and 63.8 (11.1) years in men. Mean follow-up was 5.67 (1.07) years
for women and 5.60 (1.21) years for men, yielding 802,081 and 688,570 person-years of
follow-up in women and men, respectively. The median time from fracture to death or study
end was 2.6 years. In general, participants who died were older (P<0.001), more likely to
have fractured (P<0.001), have had a prior fracture (P<0.001), have more co-morbidities
(P<0.001) and, in men, have higher smoking rates (P<0.001) than participants who did not
die during the follow-up period (Table 1).

Fracture incidence
During follow-up, women had 7,571 and men had 4,571 incident fractures, yielding fracture
incidence rates of 9.71/1000 person-years (95% CI: 9.50-9.94) in women and 7.09/1000
person-years (95% CI: 6.89-7.30) in men. Pattern of fractures were similar between women
and men (Figure 1). NHNV accounted for over 70% of fractures in both women and men.
There was an exponential increase in hip fractures, particularly after 75 years, and increased
incidence of vertebral, pelvic, rib and humeral fractures with increasing age. Distal forearm
fractures increased with age in women but not in men. By contrast, NHNV fracture at other
sites, e.g. elbow and proximal tibia/fibula, remained relatively stable with increasing age.
Women had more distal site (distal forearm and ankle) fractures than men (P<0.001).
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Mortality
Mortality rates were lower in the cohort than in the general Australian population (age
adjusted rates: 17.3 vs 25.1 /1000 in women and 21.5 vs 27.7/1000 person-years in men. For
the non-fracture study cohort, there were 5,981 deaths in 133,771 women and 10,068 deaths
in 118,306 men yielding age-standardised mortality rates of 16.9/1000 person-years (95% CI:
16.3-17.3) in women and 21.9/1000 person-years (95% CI: 20.5-23.2) in men. Among
participants who had fractured, there were 1,083 and 1092 deaths in women and men,
respectively with higher age-standardised mortality rates of 21.9/1000 person-years (95% CI:
20.5-23.2) in women and 31.4/1000 person-years (95% CI: 29.4-33.4) in men.

Specific co-morbidities associated with increased mortality included cardiovascular disease,
diabetes, stroke, and thrombotic disorders with age-adjusted mortality HRs ranging from 1.21.9 (Supplementary Table S1). Cancers other than breast or prostate were associated with the
highest mortality risk (HR: 2.1-2.2). Low and high BMI and prior and current smoking were
associated with increased mortality (HR: 1.4-2.7). Skin cancers other than melanoma were
associated with a lower age-adjusted mortality risk. Alcohol intake in the cohort was low
with 88% of women and 87% of men drinking within the recommended Australian alcohol
guidelines or not drinking at all (non-drinkers: 41% and 23% in women and men,
respectively). There was no clinically significant association between alcohol intake and
mortality for either women or men.

Fracture and mortality risk
Increased mortality was observed for many different fracture sites in both women and men.
This remained significant after multivariable adjustment (Figure 2, Supplementary Table S2).
In general, mortality risk post fracture was greater in men than women (P<0.001). As
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expected, the mortality risk post fracture was highest for the hip (women: 2.76 (95% CI: 2.46,
3.09) and men: 3.40 (95% CI: 3.05, 3.78). Fractures of the vertebrae and pelvis were
associated with increased mortality of similar magnitude. Interestingly, rib, humeral, elbow,
proximal tibia/fibula and clavicular fractures all had similar associations with mortality risk
with HRs between 2.00 and 2.50. Amongst distal fracture sites, distal forearm fractures were
associated with increased mortality risk in both women and men. Ankle fractures, however,
were only associated with an increased mortality risk in men. Mortality risk was not
increased following fracture of the hands, feet, fingers and toes and did not differ from the
non-fracture population.

The estimated survival function curves highlight the relationship between fracture event,
number of co-morbidities and survival (Figures 3a & 3b for women and men aged 60 and 80,
respectively). For these analyses, co-morbidities selected were those most common in the
cohort, namely cardiovascular disease and diabetes. These survival curves demonstrate
fracture as a risk factor for mortality, and the additional independent contribution of comorbidities. Indeed a woman with a humerus fracture and one co-morbidity had the same
estimated 5-year survival as a woman with a hip fracture and no co-morbidities. A man with
a humeral fracture and one co-morbidity had a somewhat better survival than a man with a
hip fracture and no co-morbidities but having 2 co-morbidities together with a humeral
fracture resulted in a greater 5 year mortality than a hip fracture alone.

Population attributable fraction
The proportion of deaths in the population that could be attributed to fracture in individuals
without co-morbidity was 9.2% in women and 5.3% in men. In women, the PAF was less
than cancer but of a similar magnitude to cardiovascular disease and diabetes. Fracture
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incidence was lower and cardiovascular disease higher in men than women; as a result the
PAF of any fracture in men was less than cardiovascular disease but similar to diabetes and
cancer. However, the contribution of fracture with or without any single co-morbidity
resulted in a PAF for mortality that was similar to cancer in women and cardiovascular
disease in men (Tables 2a & 2b).

Discussion
In this large population-based cohort study of subjects aged 45 and older, a large range of
NHNV fractures, in addition to hip and vertebral fractures, were associated with increased
mortality risk, after adjusting for age, prior fracture, smoking, BMI, cancer and other major
co-morbidities. Virtually all NHNV fractures, including ribs, pelvis, femur, elbow, proximal
tibia/fibula, distal forearm in both sexes, as well as ankle in men, were associated with
increased mortality post fracture with hazard ratios ranging from 1.3 to 3.4. Notably the
mortality reported represents an early post fracture mortality with median time of 2.6 years
from fracture to death or study end. Peripheral fractures of hands and feet were not associated
with increased mortality. Moreover, this study demonstrated that co-morbidity contributed to
mortality independently and additively from the fracture itself. The proportion of deaths that
could be attributable to subjects with fracture alone or with fracture and one co-morbidity
was of a similar magnitude to other major illnesses including cancer and heart disease,
highlighting the magnitude of the problem.

We found that hip and vertebral fractures were associated with 3.0-fold and 2.7-fold increase
in mortality, respectively, similar to previous reports (3). In relation to NHNV post-fracture
mortality, humeral fractures have been the most frequently studied, with consistent findings
of increased mortality (2, 15, 17, 18). Our study supports these findings, demonstrating
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humeral fractures were associated with a two-fold increase in mortality in women (HR: 2.0)
and men (HR: 1.95) after multivariable adjustment. Prior studies which have demonstrated
increased mortality have not always discriminated by sex (2) and none has adjusted for comorbidities (2, 15, 17, 18). Adjustment for co-morbidities in the current study had minimal
effect on the fracture-mortality association itself but added an additional independent
contribution to mortality.

The relationship between distal forearm fractures and mortality is controversial with
conflicting data. Studies have variously reported increased (8, 27), similar (2, 7, 20, 28) or
decreased mortality (16, 19). We found significant mortality increases of 30% and 50% (HR
1.30 and 1.50) in women and men, respectively and of a similar magnitude to the large
Norwegian and Korean studies (8, 27). Previously published studies that did not find an
association between mortality and distal forearm fractures may have been hindered by low
fracture numbers (often below 200). Studies reporting increased mortality post distal forearm
fractures generally had larger fracture numbers (27). Bliuc et al (5) found a group of minor
fractures, including distal forearm, were associated with increased mortality but only in
subjects >75 years, with insufficient forearm fractures for separate analysis. In a Medicaid
US dataset where decreased mortality post distal forearm fractures was demonstrated (19),
the authors postulated increased contact with the healthcare system as the cause. Unlike the
USA, Australia has universal healthcare at all ages, perhaps explaining differences in
findings between the USA and the current study.

Few studies have examined mortality after rib fractures. Of these, only three examined rib
fractures as a distinct group. The Study of Osteoporotic Fractures reported a three-fold
increased mortality following rib fractures in women (29). Of the remaining two studies, one
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found no difference in mortality risk but with only 16 and 11 rib fractures in men and
women, respectively (25). In the other study (21) increased mortality risk post rib fractures
was observed for women but not men. By contrast, in the current study, rib fractures were
associated with an increased mortality risk of similar magnitude (two-fold) to vertebral
fractures in both women and men.

There is particularly limited evidence about other NHNV fracture sites. Previous studies
generally did not find any association between mortality and other NHNV fractures but were
limited by small numbers, leading to grouping of fractures and inability to adjust for comorbidities. Piirtola et al. did not find any association between “other miscellaneous”
fractures (fractures other than hip, vertebra, ribs, proximal humerus and ankle) and mortality,
but there were only 47 fractures over 12 years (12). Melton et al. reported “other arm”
fractures (excluding proximal humerus and distal forearm) being associated with increased
one-year mortality (13). In the same study, the “other leg group” of fractures (all lower limb
fractures other than hip, feet and toes), did not show increased mortality. We found two- to
three-fold increased mortality following proximal tibia/fibula, elbow and distal femur
fractures in both sexes.

The specific causes of excess mortality following fracture are poorly understood. The
duration of increased mortality attributable to fractures is also questionable, so pre-fracture
co-morbidities have been hypothesised to contribute significantly to excess mortality with the
fracture being a signal of underlying frailty. Several studies have examined the role of comorbidities, mainly following hip fracture (30-32). A large Danish hip fracture study did not
demonstrate any association between mortality and pre-fracture co-morbidities (31). The
major identified causes of mortality were post fracture complications. In the Fracture
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Intervention Trial, adjustment for co-morbidities also did not affect mortality hazard ratios
(28). Similarly, adjustment for co-morbidities in our study had minimal effect on the fracturespecific hazard ratios although the presence of co-morbidities contributed additively and
independently to mortality. Apart from the post fracture mortality, it has been demonstrated
that low bone density (33), sarcopenia (34, 35), low body weight (21) and weight loss are
independent predictors of both fracture and mortality and thus may play a role in any post
fracture associated mortality. However, these variables are generally not available in large
registry studies.

One criticism of studies in this area is that control groups are often healthier with fewer comorbidities. The current study addressed this using both estimated survival curves and the
heuristic approach to calculating population attributable fraction. The estimated survival
curves demonstrate visually the difference in mortality risks between an individual with none,
one or two co-morbidities following a fracture. In an individual with co-morbidities, fracture
and co-morbidity were each independent risk factors for mortality, while the combination of
both increased mortality risk. Indeed, a woman with a humeral fracture and one co-morbidity
had a similarly reduced 5 year survival to that of a woman with a hip fracture and no comorbidities. Moreover, a fracture with either no or one co-morbidity, accounted for 19% of
the deaths in women and 11% in men, which was similar to that for any other individual cocomorbidity including both cancer and cardiovascular disease. Both approaches support
fracture as an independent risk factor for mortality and the latter analysis demonstrates the
significant contribution of fracture to overall population mortality.

The strengths of the current study include the large sample size of women and men giving
statistical power to study individual fracture sites. Unlike previous studies, this dataset
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captures both community and inpatient data, allowing adjustment for lifestyle factors and
medical co-morbidities. Furthermore, the study is the first to estimate population attributable
fraction for each level of exposure and delineate the independent and additive effects of comorbidity to fracture-associated mortality.

The limitations of the study include potential underestimation of mortality risk associated
with fracture, as 45 and Up Study cohort mortality rates were significantly lower than the
general NSW population. However, as increased mortality risk was still observed in this
healthy group with fracture, it is likely that this risk would still be evident, and possibly
higher, in the general population with a greater number of co-morbidities. Fractures were
identified from administrative hospital data so it is possible that not all high trauma fractures
were excluded or that only more severe distal fractures were included, potentially
overestimating mortality risk in this group. Moreover, the specifics of the fracture event
itself was not able to be determined given the nature of the study. While validity of deaths
and fracture data is high, validity of self-reported co-morbidities has not been well studied.
However, administrative datasets are likely to under report co-morbid conditions compared
with self-report (36). Medication use was not available in the current study so any effect of
medication on survival could not be evaluated.

Conclusion
In this large cohort of healthy community-dwelling people, a wide range of non-hip nonvertebral fractures were associated with increased mortality after multivariable adjustment.
Importantly these NHNV fractures accounted for approximately 75% of fractures in this
study. Compared to the non-fracture group, women and men with any fracture had a 19% and
25% higher mortality rate, respectively. The population attributable fraction of mortality for
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any fracture was 9.2% in women and 5.3% in men, similar in magnitude to other well
described causes of mortality including cardiovascular disease, diabetes and cancer.
Moreover, using estimated survival curves, this study demonstrated for the first time that
individuals with co-morbidities had worse survival after a fracture than those who fractured
but were co-morbidity free. This study highlights the potential benefit of early intervention
after fracture to reduce risk of further fractures and possibly decrease mortality.
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Table 1: Participant characteristics by sex and mortality outcome
Women (N = 141,342)
Variable

Age, mean (SD),

Men (N = 122,877)

Alive

Died

Alive

Died

(n = 134,278)

(n = 7,064)

(n = 111,799)

(n=11,078)

61.0 (10.5)

76.7 (11.7)*

62.5 (10.4)

76.2 (10.2)*

26.7 (5.3)*

25.8 (5.7)

27.3 (4.2)*

26.2 (4.7)

yrs
BMI, mean
(SD), kg/m2
Fracture (%)

6,488 (4.8)

1,083 (15.3)*

3,561 (3.2)

1,010 (9.1)*

Prior fracture

16,071 (12.0)

1,509 (21.4)*

9,129 (8.2)

1,134 (10.2)*

47,178 (35.3)

2,506 (35.6)

55,834 (50.1)

6,920 (62.8)*

9,775 (7.3)

1,693 (24.0)*

16,279(14.6)

3,603 (32.5)*

44,004 (32.8)

3,230 (45.7)*

41,611 (37.2)

5,002 (45.2)*

Diabetes (%)

9,154 (6.8)

1,073 (15.2)*

11,267 (10.1)

2,167 (19.6)*

Stroke (%)

2,964 (2.2)

718 (10.2)*

3,421 (3.1)

1,187 (10.7)*

Thrombosis (%)

7,058 (5.3)

711 (10.1)*

3,606 (3.2)

757 (6.8)*

within last 5
yrs (%)
Ever smoked
(%)

Diseases
Cardiovascular
disease (%)
Hypertension
(%)
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Cancer (%)

14,075 (10.5)

1,829 (25.9)*

11,052 (9.9)

3,158 (28.5)*

*P<0.001 for died vs alive
Table 2a: Population attributable fraction (Women)

Population

Number

Deaths

Person-

Mortality

years

rate (/1000

PAF (%)

Personyears)
97,672

2,488

560,591

4.4

Fracture only

4,684

455

26,837

17.0

9.2

Cardiovascular

6,118

616

33,700

18.3

13.3

Diabetes

6,016

368

33,745

10.9

6.1

Cancer

10,965

922

60,678

15.2

18.5

Stroke

1,434

188

7,795

24.1

4.4

Thrombosis

4,272

176

24,364

7.2

1.9

Fracture & 1 co-

2,074

394

11,333

34.8

10.0

No fracture/comorbidity

morbidity
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Table 2b: Population attributable fraction (Men)

Population

Number

Deaths

Person-

Mortality

years

rate (/1000

PAF (%)

Person-years)
81,300

4,252

463,458

9.2

2,746

411

15,517

26.5

5.3

12,201

1,659

66,776

24.8

21.3

Diabetes

7,914

839

41,920

19.1

8.7

Cancer

4,391

698

23,576

29.6

10.0

Stroke

1,769

336

9,505

35.3

5.2

Thrombosis

2,059

212

11,547

18.4

2.1

Fracture & 1

1,237

355

6,596

53.8

6.2

No fracture/comorbidity
Fracture only
Cardiovascular

co-morbidity

21
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